Zobrazeno 1 - 10
of 81
pro vyhledávání: '"ROMINA LOMONACO"'
Autor:
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Reginald Frye, Eddison Godinez Leiva, Kenneth Cusi
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101092- (2024)
Background & Aims: It has been postulated that carriers of PNPLA3 I148M (CG [Ile/Met] or GG [Met/Met]) develop metabolic dysfunction-associated steatotic liver disease (MASLD) in the absence of insulin resistance or metabolic syndrome. However, the r
Externí odkaz:
https://doaj.org/article/c27cb77df685452e953139bddaf23c08
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 108:483-495
ContextNonalcoholic fatty liver disease (NAFLD) is associated with obesity and type 2 diabetes (T2D), causing substantial burden from hepatic and extrahepatic complications. However, endocrinologists often follow people who are at the highest risk of
Publikováno v:
Diabetes, obesitymetabolismREFERENCES.
Autor:
Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, Xiaofei Chi, Sulav Shrestha, Rachel Dillard, Jeffery Budd, Jessica Portillo Romero, Christina Li, Fernando Bril, George Samraj, John Pennington, Petra Townsend, Frank Orlando, Shwetha Shetty, Lydia Mansour, Lorena Rodrigues Silva-Sombra, Pierre Bedossa, John Malaty, Diana Barb, Matthew J Gurka, Kenneth Cusi
Publikováno v:
The Journal of clinical endocrinology and metabolism.
Context Although type 2 diabetes (T2D) is a risk factor for liver fibrosis in nonalcoholic fatty liver disease (NAFLD), the specific contribution of insulin resistance (IR) relative to other factors is unknown. Objective Assess the impact on liver fi
Autor:
Meagan Gray, Charles M. Rowland, Michael J. McPhaul, Kenneth Cusi, Dov Shiffman, Romina Lomonaco, Srilaxmi Kalavalapalli, Fernando Bril, Diana Barb
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e4360-e4371
Context Patients with nonalcoholic fatty liver disease (NAFLD) are characterized by insulin resistance and hyperinsulinism. However, insulin resistance measurements have not been shown to be good diagnostic tools to predict NAFLD in prior studies. Ob
Autor:
APRIL MATHEWS, SRILAXMI KALAVALAPALLI, EDDISON GODINEZ, ROMINA LOMONACO, RACHEL E. DILLARD, MARIA A. GONZALEZ, STEPHEN A. MARANGI, SHWETHA S. SHETTY, SULAV SHRESTHA, LYDIA MANSOUR, MARGERY A. CONNELLY, KELLY Y. CHUN, DIANA BARB, KENNETH CUSI
Publikováno v:
Diabetes. 71
Obesity (OB) and type 2 diabetes (T2D) are associated with NAFLD and a worse cardiometabolic profile. However, their independent contribution to steatosis, fibrosis, insulin resistance (IR) and atherogenic dyslipidemia are controversial. To this end,
Autor:
Jeff Budd, Srilaxmi Kalavalapalli, Nada Fanous, Danielle Poulton, Fernando Bril, Diana Barb, Pierre Bedossa, Jonathan S. Marte, Eddison Godinez Leiva, Sulav Shrestha, Romina Lomonaco, Ku-Lang Chang, John Malaty, George P. N. Samraj, Jessica Portillo Romero, Kenneth Cusi, Siegfried Schmidt, Lydia Mansour, Katherine Huber
Publikováno v:
Diabetes Care
OBJECTIVE Assess the prevalence of nonalcoholic fatty liver disease (NAFLD) and of liver fibrosis associated with nonalcoholic steatohepatitis in unselected patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS A total of 561 pat
Publikováno v:
Journal of Hepatology. 72:401-410
Proof-of-concept studies frequently assess changes in intrahepatic triglyceride (IHTG) content by magnetic resonance-based techniques as a surrogate marker of histology. The aim of this study was to establish how reliable this strategy is to predict
Autor:
Kenneth Cusi, Eddison Godinez, Michael J. McPhaul, Romina Lomonaco, Diana Barb, Fernando Bril, Srilaxmi Kalavalapalli
Publikováno v:
Diabetes. 70
Patients with NAFLD are characterized by insulin resistance (IR) and hyperinsulinism. However, prior studies have been unable to predict NAFLD based on IR measurements. The aim of this study was to explore the application of a newly validated measure